Literature DB >> 20807589

Regulatory T cells: the suppressor arm of the immune system.

Sheila Langier1, Kobe Sade, Shmuel Kivity.   

Abstract

The existence of a population of lymphocytes with suppressor activity able to inhibit immune responses has been widely studied. The greatest advances were made when researchers proposed markers, such as CD25 and Foxp3, for identifying those suppressor T cells. Regulatory T cells (Tregs) represent approximately 10% of the CD4 T cells and are able to suppress the immune responses to self and foreign antigens. Tregs can develop and acquire a suppressor phenotype in the thymus (natural Tregs) or be induced in the periphery followed certain activation and antigen presentations conditions (induced Tregs). These cells can suppress the immunological system by two principal pathways: the direct suppression of the target cells by cell-contact, and by the secretion of suppressor cytokines. This review summarizes the published data on Tregs and its suggested role in various states of health and disease.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807589     DOI: 10.1016/j.autrev.2010.08.013

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  8 in total

1.  The roles of IL-2 and IL-10 enhance anti-CD45RBmAb immune inhibition in allograft skin.

Authors:  Wei-Jian Guo; Hui Qi; Chun-Yan Deng; Han-Xin Zhou; Shao-Ping Deng; Fu-Rong Li
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

2.  GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis.

Authors:  Jian Rong Sheng; Thiruppathi Muthusamy; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  J Neuroimmunol       Date:  2011-11-17       Impact factor: 3.478

Review 3.  Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab.

Authors:  Francesco Caso; Luca Iaccarino; Silvano Bettio; Francesca Ometto; Luisa Costa; Leonardo Punzi; Andrea Doria
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

4.  Dynamic Frequency of Blood CD4+CD25+ Regulatory T Cells in Rats with Collagen-induced Arthritis.

Authors:  Tingyu Wang; Jun Li; Zhigui Jin; Feihua Wu; Yunwu Li; Xiaohua Wang; Hong Zhou; Qian Zhou
Journal:  Korean J Physiol Pharmacol       Date:  2015-02-25       Impact factor: 2.016

Review 5.  The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells.

Authors:  D H Lewis; D L Chan; D Pinheiro; E Armitage-Chan; O A Garden
Journal:  J Vet Intern Med       Date:  2012-03-17       Impact factor: 3.333

Review 6.  Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.

Authors:  Milan Buc
Journal:  Mediators Inflamm       Date:  2013-05-12       Impact factor: 4.711

7.  Role of CD25(+) CD4(+) T cells in acute and persistent coronavirus infection of the central nervous system.

Authors:  Maria Teresa P de Aquino; Shweta S Puntambekar; Carine Savarin; Cornelia C Bergmann; Timothy W Phares; David R Hinton; Stephen A Stohlman
Journal:  Virology       Date:  2013-09-24       Impact factor: 3.616

Review 8.  Mucosal immunity to poliovirus.

Authors:  Ruth I Connor; Elizabeth B Brickley; Wendy F Wieland-Alter; Margaret E Ackerman; Joshua A Weiner; John F Modlin; Ananda S Bandyopadhyay; Peter F Wright
Journal:  Mucosal Immunol       Date:  2021-07-08       Impact factor: 7.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.